Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Tokyo - Delayed Quote JPY

Shinnihonseiyaku Co., Ltd. (4931.T)

Compare
2,187.00
-109.00
(-4.75%)
At close: April 4 at 3:30:00 PM GMT+9
Loading Chart for 4931.T
  • Previous Close 2,296.00
  • Open 2,220.00
  • Bid 2,175.00 x --
  • Ask 2,191.00 x --
  • Day's Range 2,141.00 - 2,246.00
  • 52 Week Range 1,510.00 - 2,395.00
  • Volume 52,900
  • Avg. Volume 39,922
  • Market Cap (intraday) 46.191B
  • Beta (5Y Monthly) 0.51
  • PE Ratio (TTM) 16.92
  • EPS (TTM) 129.25
  • Earnings Date May 12, 2025 - May 16, 2025
  • Forward Dividend & Yield 87.00 (3.98%)
  • Ex-Dividend Date Sep 29, 2025
  • 1y Target Est 2,190.00

Shinnihonseiyaku Co., Ltd. provides cosmetics, pharmaceuticals, and health food in Japan and internationally. It operates through Mail Order, Direct Store Sales/Wholesale Sales, and Overseas Sales segments. The company provides skincare products under the Perfect One and Perfect One Focus brands; and pharmaceutical products for various diseases and symptoms. It operates a network of stores, and online shops. The company was formerly known as Shinnihonliving Co., Ltd. and changed its name to Shinnihonseiyaku Co., Ltd. in April 2002. The company was incorporated in 1992 and is headquartered in Fukuoka City, Japan.

corporate.shinnihonseiyaku.co.jp/en/

316

Full Time Employees

September 30

Fiscal Year Ends

Recent News: 4931.T

View More

Performance Overview: 4931.T

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

4931.T
8.11%
Nikkei 225 (^N225)
15.33%

1-Year Return

4931.T
32.85%
Nikkei 225 (^N225)
15.07%

3-Year Return

4931.T
54.93%
Nikkei 225 (^N225)
21.79%

5-Year Return

4931.T
159.87%
Nikkei 225 (^N225)
89.56%

Compare To: 4931.T

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 4931.T

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    46.19B

  • Enterprise Value

    30.10B

  • Trailing P/E

    16.92

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.18

  • Price/Book (mrq)

    2.12

  • Enterprise Value/Revenue

    0.75

  • Enterprise Value/EBITDA

    6.69

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    7.51%

  • Return on Assets (ttm)

    11.17%

  • Return on Equity (ttm)

    15.00%

  • Revenue (ttm)

    40.57B

  • Net Income Avi to Common (ttm)

    3.05B

  • Diluted EPS (ttm)

    129.25

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    15.57B

  • Total Debt/Equity (mrq)

    1.01%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: 4931.T

View More

Company Insights: 4931.T

Research Reports: 4931.T

View More

People Also Watch